Search Results 781-790 of 18507 for Prednisone

  1. Tacrolimus (topical route) - Mayo Clinic

    Atopic dermatitis is a skin condition where there is itching, redness, and inflammation, much like an allergic reaction. Tacrolimus helps to suppress these ...

  2. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    ... prednisone or equivalent), systemic immunosuppressant medications may be enrolled in the study. The use of corticosteroids (≤ 10 mg oral prednisone or ...

  3. Belimumab in Remission of VASculitis - Clinical Trials

    Remission is defined as a Birmingham Vasculitis Activity (BVAS) score of 0 and receiving less than 10 mg/day of oral prednisone (or equivalent) on 2 consecutive ...

  4. A Study to Estimate the Clinical Benefit of REGN2810 for Patients with Advanced Squamous Cell Skin Cancer

    Immunosuppressive corticosteroid doses (>10 mg prednisone daily or equivalent) within 4 weeks prior to the first dose of REGN2810; Infection with human ...

  5. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Treatment with corticosteroids at a dose that exceeds the prednisone equivalent of 40 mg per day;; Treatment with immunosuppressive agents (e.g. ...

  6. Health Topics - Mayo Clinic News Network

    The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...

  7. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    ... prednisone within 30 days before the first dose of study treatment on W1D1: Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

  8. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

    Must be on a stable dose of oral prednisolone or prednisone of ≥7.5 mg/day (but not \>50mg/day) for at least 4 weeks prior to randomization. 5. If ...

  9. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... prednisone or equivalent corticosteroid at the time of registration. Eastern Cooperative Oncology Group (ECOG) performance status 0-2; Patients with active ...

  10. Keloid scar - Diagnosis and treatment - Mayo Clinic

    Wound care. For newer keloids, the first treatment option might be compression dressings made from stretchy fabric or other materials. · Corticosteroid cream.